Komori
Statutory disclosure document4888STELLA PHARMA CORPORATIONPharmaceuticals

Report on the Transfer of Shares Issued Through a Third-Party Allotment (New Shares)

The 1,000,000 common shares allotted to CVI Investments, Inc. through a third-party allotment were transferred to BofA Securities Co., Ltd. in an off-market transaction. The transfer date was 2 September 2026, and the total transfer amount was ¥355 million.

Worth reading
68In focus
Scored from 5 of 6 sections
Direction
Neutral
Direction inferred from the company’s description.
Scale
355000000
Yen (total transfer amount)
Wording
Definitive
How definitive the wording is.

Decision and Details

Transfer of shares allotted through a third-party allotment

Implementation2 September 2026 (actual)
AmountTransfer price: ¥355,000,000 in total (¥355 per share)
Quantity / scale1,000,000 common shares
Reason

For the purpose of moving the shares to a swap position

Decision and Details
ItemDetails
Matter CoveredTransfer of shares allotted through a third-party allotment
Implementation Date2 September 2026 (actual)
AmountTransfer price: ¥355,000,000 in total (¥355 per share)
Quantity / scale1,000,000 common shares
ReasonFor the purpose of moving the shares to a swap position
Items this document does not state (7)
Decision-Making BodyDecision DatePeriod CoveredImpact on Business PerformanceGoverning RuleRelated previous disclosuresFuture plans

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

For the purpose of moving the shares to a swap position.

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
Report on the Transfer of Shares Issued Through a Third-Party Allotment (New Shares) | STELLA PHARMA CORPORATION (4888) timely disclosure | Komori